| Particulars |
| Company Name |
Concord Biotech Ltd |
| Face Value |
1 |
| BSE Code |
543960 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
10.46 |
| B.V. Rs |
193.10 |
| Sales Rs in Cr. |
1,055.07 |
| NP Rs in Cr. |
265.72 |
| NP Var% |
-25.00 |
| Div% |
755.00 |
| CPS Rs |
32.50 |
| EPS Rs |
25.40 |
| Traded Value(Rs in Lakhs) |
848.51 |
| 52 Week High |
2,150.00 |
| 52 Week Low |
987.00 |
| Price BSE |
1,167.00 |
| Price NSE |
1,166.00 |
| Market Capital(Rs in Cr.) |
12,206.62 |
| P/C Ratio |
35.90 |
| P/E Ratio |
45.90 |
| Price Vs.BV |
6.04 |
| Latest Quarter |
| Year End |
202603 |
| Sales Rs in Cr. |
325.89 |
| NP Rs in Cr. |
90.02 |
| NP Var % |
-37.00 |
| Trailing Twelve Months |
| Year End |
202603 |
| Sales |
1,085.75 |
| OPM |
42.50 |
| NP |
328.71 |
| NP Var% |
-25.44 |
| EPS |
25.40 |
| PE |
45.94 |
|